Videos

Adare Pharmaceuticals' Cheryl Wood

Adare Pharmaceuticals' Cheryl Wood

Adare's director of business development discusses solid dose formulations, amongst other capabilities.

By Contract Pharma Staff11.18.19
Cheryl Wood discusses Adare's solid dose formulations, amongst other capabilities. Find out how Adare's team ensures the right drug for the right patient in the right form.
Related Searches:
Suggested For You
Aphena Adds Cold Chain Storage, Biologics Packaging and Distribution Aphena Adds Cold Chain Storage, Biologics Packaging and Distribution
Frontida BioPharm Names Steven Roese as Vice President, Quality Frontida BioPharm Names Steven Roese as Vice President, Quality
Capsule Technology Trends Capsule Technology Trends
Why is the sterility of your drug product much more than just a test of sterility? Why is the sterility of your drug product much more than just a test of sterility?
Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies
Preclinical Planning for Successful Drug Development Preclinical Planning for Successful Drug Development
Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach
Embedding your Drug Strategy Within a Solid Foundation for Success Embedding your Drug Strategy Within a Solid Foundation for Success
Drug Safety and Pharmacovigilance: Effective Drug Safety Reporting and Surveillance Drug Safety and Pharmacovigilance: Effective Drug Safety Reporting and Surveillance
Monitoring Clinical Drug Studies: Beginner Monitoring Clinical Drug Studies: Beginner
EU Compassionate Use Programs - Where’s My Drug? EU Compassionate Use Programs - Where’s My Drug?
Introduction to PCI Drug Development and Manufacturing Services Introduction to PCI Drug Development and Manufacturing Services
Piramal, Bolt Enter Drug Development Deal Piramal, Bolt Enter Drug Development Deal
ChemWerth Files its 500th Drug Master File with FDA ChemWerth Files its 500th Drug Master File with FDA
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing

Related Videos